PMID- 11642397
OWN - NLM
STAT- MEDLINE
DCOM- 20020226
LR  - 20190906
IS  - 0275-004X (Print)
IS  - 0275-004X (Linking)
VI  - 21
IP  - 5
DP  - 2001
TI  - Central serous chorioretinopathy in a patient using methylenedioxymethamphetamine 
      (MDMA) or "ecstasy".
PG  - 559-61
FAU - Hassan, L
AU  - Hassan L
AD  - LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear, and Throat 
      Hospital, New York, New York 10021, USA.
FAU - Carvalho, C
AU  - Carvalho C
FAU - Yannuzzi, L A
AU  - Yannuzzi LA
FAU - Iida, T
AU  - Iida T
FAU - Negrao, S
AU  - Negrao S
LA  - eng
PT  - Case Reports
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Retina
JT  - Retina (Philadelphia, Pa.)
JID - 8309919
RN  - 0 (Adrenergic Uptake Inhibitors)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - Adrenergic Uptake Inhibitors/*adverse effects
MH  - Adult
MH  - Choroid Diseases/*chemically induced/diagnosis
MH  - Exudates and Transudates
MH  - Humans
MH  - Male
MH  - N-Methyl-3,4-methylenedioxyamphetamine/*adverse effects
MH  - Retinal Diseases/*chemically induced/diagnosis
EDAT- 2001/10/20 10:00
MHDA- 2002/02/28 10:01
CRDT- 2001/10/20 10:00
PHST- 2001/10/20 10:00 [pubmed]
PHST- 2002/02/28 10:01 [medline]
PHST- 2001/10/20 10:00 [entrez]
AID - 10.1097/00006982-200110000-00030 [doi]
PST - ppublish
SO  - Retina. 2001;21(5):559-61. doi: 10.1097/00006982-200110000-00030.